byiShook Opinion
Apr 2, 2025 - 13:35
Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide. The post Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch appeared first on Investor's Business Daily.
Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.
The post Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch appeared first on Investor's Business Daily.